Debt to Equity Ratio Chart

View Debt to Equity Ratio for EXAS:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1999. Start Trial.
Date Value
December 31, 2025 1.056
September 30, 2025 1.014
June 30, 2025 1.027
March 31, 2025 1.059
December 31, 2024 1.156
September 30, 2024 0.8662
June 30, 2024 0.8721
March 31, 2024 0.8219
December 31, 2023 0.816
September 30, 2023 0.8248
June 30, 2023 0.8413
March 31, 2023 0.8421
December 31, 2022 0.8075
September 30, 2022 0.7905
June 30, 2022 0.7652
March 31, 2022 0.7366
December 31, 2021 0.7087
September 30, 2021 0.6949
June 30, 2021 0.6743
March 31, 2021 0.655
December 31, 2020 1.051
September 30, 2020 0.7405
June 30, 2020 0.675
March 31, 2020 0.6565
December 31, 2019 0.4174
Date Value
September 30, 2019 1.118
June 30, 2019 1.089
March 31, 2019 1.058
December 31, 2018 1.023
September 30, 2018 0.9396
June 30, 2018 0.8778
March 31, 2018 0.7148
December 31, 2017 0.0086
September 30, 2017 0.0089
June 30, 2017 0.0087
March 31, 2017 0.0154
December 31, 2016 0.0143
September 30, 2016 0.0134
June 30, 2016 0.0196
March 31, 2016 0.0171
December 31, 2015 0.0154
September 30, 2015 0.0137
June 30, 2015 0.017
March 31, 2015 0.0049
December 31, 2014 0.0047
September 30, 2014 0.0067
June 30, 2014 0.0063
March 31, 2014 0.0133
December 31, 2013 0.0126
September 30, 2013 0.0124

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Quest Diagnostics, Inc. 0.8697
Illumina, Inc. 0.9507
Mettler-Toledo International, Inc. -53.21
Natera, Inc. 0.1353
Abbott Laboratories 0.654